首页> 外文期刊>Journal of Cancer >A Retrospective Clinicopathological Study of Osteosarcoma Patients with Metachronous Metastatic Relapse
【24h】

A Retrospective Clinicopathological Study of Osteosarcoma Patients with Metachronous Metastatic Relapse

机译:骨肉瘤异时转移性复发的回顾性临床病理研究

获取原文
获取外文期刊封面目录资料

摘要

Purpose : Although osteosarcoma patients receive a standardized treatment, metachronous metastatic relapse still impairs the overall survival (OS). This study aimed to explore the clinicopathological features and prognostic factors of osteosarcoma patients with metachronous metastatic relapse. Patients and methods : We retrospectively analyzed 59 patients, between January 1st, 2004 and December 31st, 2013. Employed Chi-square test to recognize the differences in clinicopathological characteristics between early and late metastatic patients, and the differences between shorter and longer survival patients. Used the Kaplan-Meier method to evaluate the survival data, cox step proportional hazard test to analyze the prognostic factors associated with OS. Results : We found that early metastatic patients were prominently correlated with the male, tumor size ≥8 cm, histological grade G2, Enneking stages II, anatomic location of the distal femur, pathological of conventional types, and elevated alkaline phosphatase (ALP) level at diagnosis, (p0.05). In parallel, the shorter survival patients were primarily linked to tumor size ≥8 cm, histological grade G2, Enneking stages II, early metastasis, multiple pulmonary metastases, lack of curative treatment after metastasis, increased level of ALP at diagnosis and LDH after metastasis, (p0.05). The univariate analyses of the prognostic factors showed that patients who had these clinicopathological characteristics, such as male, tumor size ≥8 cm, Enneking stage IIB, multiple pulmonary metastases, lack of curative treatment after metastasis, the elevated ALP at diagnosis, elevated ALP and LDH after metastasis, had a worse OS in osteosarcoma patient with metachronous metastatic relapse, (p0.05). The multivariate analyses showed that tumor size, type of metastasis and ALP level at diagnosis were independent factors for OS in osteosarcoma patient with metachronous metastatic relapse (p0.05). Conclusion : These results indicated that osteosarcoma patients with metachronous metastatic relapse have special features which might be utilized to effectively predict the likelihood of early metastatic relapse and the prognosis.
机译:目的:尽管骨肉瘤患者接受标准化治疗,但异时转移性复发仍会损害总生存期(OS)。这项研究旨在探讨骨肉瘤转移性复发的临床病理特征和预后因素。患者和方法:我们回顾性分析了2004年1月1日至2013年12月31日之间的59例患者。采用卡方检验来识别早期和晚期转移性患者之间临床病理特征的差异,以及较短和较长生存期患者之间的差异。使用Kaplan-Meier方法评估生存数据,进行Cox步骤比例风险测试以分析与OS相关的预后因素。结果:我们发现早期转移患者与男性,肿瘤大小≥8cm,组织学等级G2,Enneking II期,股骨远端的解剖位置,常规类型的病理以及碱性磷酸酶(ALP)水平升高之间存在显着相关性。诊断(p <0.05)。同时,生存期较短的患者主要与肿瘤尺寸≥8cm,组织学等级G2,Enneking II期,早期转移,多发肺转移,转移后缺乏治疗,诊断时ALP水平升高和转移后LDH有关, (p <0.05)。对预后因素的单因素分析表明,具有以下临床病理特征的患者:男性,肿瘤大小≥8cm,Enneking IIB期,多发性肺转移,转移后缺乏治疗,诊断时的ALP升高,ALP升高和转移性复发的骨肉瘤患者转移后的LDH的OS较差(p <0.05)。多元分析表明,肿瘤大小,转移类型和诊断时的ALP水平是骨肉瘤伴转移性复发的OS的独立因素(p <0.05)。结论:这些结果表明骨肉瘤转移复发的病人具有特殊的特征,可以有效地预测早期转移复发的可能性和预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号